Tamsul osin Hydr ochloide 4 00 mcg Ca psule s TajPhar ma : Us es, Side E ffe cts, Intera ctions, Picture s, Warni

ngs, Tamsulosin Hydrochl oride Dosage & Rx I nfo | Tams ulosin Hy drochloride Uses, Side E ffects - gastro-re sistant, Ta msulosin Hydr ochl oride : Indications, Side E ffe cts, War nings, Ta msul osin Hy drochl oride - Drug I nformation - TajP harma, Ta ms ulosin Hy drochloride dose Taj phar mace uticals Ta msul osin Hydr ochl oride intera ctions, Taj P harma ceuti cal Tams ulosi n Hydrochlori de contraindi cations, Ta ms ulosi n Hydrochloride price, Ta ms ulosin Hydrochloride TajPhar ma Antihyperten sive Tams ulosi n Hydrochl oride Ca psule s SMPC - TajPhar ma Stay connecte d to all update d on Ta ms ulosin Hydrochloride Taj Phar mace uticals Taj pharma ceutical s Mumbai. Patient I nformation Lea flets, SMPC.

Tamsulosin Hydrochloride For oral use.

The capsule must be swallowed whole and must
400mcg Modified-Release not be crunched or chewed as this interferes with
Capsules the modified release of the active ingredient.
4.3 Contraindications
• Hypersensitivity to the active substance,
1. Name of the medicinal including drug-induced angioedema, or to any of
product the excipients listed in section 6.1.
Tamsulosin Hydrochloride 400mcg Modified- • A history of orthostatic hypotension.
Release Capsules Taj Pharma • Severe hepatic insufficiency.
2. Qualitative and quantitative 4.4 Special warnings and precautions for use
As with other α1-adrenoceptor antagonists, a
composition reduction in blood pressure can occur in
Each hard modified-release capsule contains: individual cases during treatment with
Tamsulosin Hydrochloride USP 400mcg tamsulosin, as a result of which, rarely, syncope
Excipients q.s. can occur. At the first signs of orthostatic
hypotension (dizziness, weakness), the patient
3. Pharmaceutical form should sit or lie down until the symptoms have
Modified-release capsule, hard. disappeared.
Orange body/olive-green cap. The capsules Before therapy with tamsulosin is initiated, the
contain white to off-white spheres. patient should be examined in order to exclude
the presence of other conditions, which can
4. Clinical particulars cause the same symptoms as benign prostatic
hyperplasia. Digital rectal examination and,
4.1 Therapeutic indications
when necessary, determination of prostate
Lower urinary tract symptoms (LUTS)
specific antigen (PSA) should be performed
associated with benign prostatic hyperplasia
before treatment and at regular intervals
(BPH).
afterwards.
4.2 Posology and method of administration
The treatment of severely renal impaired
Posology
patients (creatinine clearance of <10 ml/min)
One capsule a day to be taken after breakfast or should be approached with caution as these
the first meal of the day. patients have not been studied.
Patients with renal impairment Angioedema has been rarely reported after the
No dose adjustment is warranted in renal use of tamsulosin. Treatment should be
impairment. discontinued immediately, the patient should be
monitored until disappearance of the oedema,
Patients with hepatic impairment
and tamsulosin should not be re-administered.
No dose adjustment is warranted in patients with
The 'Intraoperative Floppy Iris Syndrome' (IFIS,
mild to moderate hepatic insufficiency (see also
a variant of small pupil syndrome) has been
section 4.3, Contraindications).
observed during cataract or glaucoma surgery in
Paediatric population some patients on or previously treated with
The safety and efficacy of tamsulosin in children tamsulosin. IFIS may increase the risk of eye
< 18 years have not been established. Currently complications during and after the operation.
available data are described in section 5.1. Discontinuing tamsulosin 1-2 weeks prior to
Method of administration cataract or glaucoma surgery is anecdotally
 Tamsul osin Hydr ochloide 4 00 mcg Ca psule s TajPhar ma : Us es, Side E ffe cts, Intera ctions, Picture s, Warni ngs, Tamsulosin Hydrochl oride Dosage & Rx I nfo | Tams ulosin Hy drochloride Uses, Side E ffects - gastro-re sistant, Ta msulosin Hydr ochl oride : Indications, Side E ffe cts, War nings, Ta msul osin Hy drochl oride - Drug I nformation - TajP harma, Ta ms ulosin Hy drochloride dose Taj phar mace uticals Ta msul osin Hydr ochl oride intera ctions, Taj P harma ceuti cal Tams ulosi n Hydrochlori de contraindi cations, Ta ms ulosi n Hydrochloride price, Ta ms ulosin Hydrochloride TajPhar ma Antihyperten sive Tams ulosi n Hydrochl oride Ca psule s SMPC - TajPhar ma Stay connecte d to all update d on Ta ms ulosin Hydrochloride Taj Phar mace uticals Taj pharma ceutical s Mumbai. Patient I nformation Lea flets, SMPC.

considered helpful, but the benefit of treatment finasteride during in vitro studies with liver
discontinuation has not yet been established. microsomal fractions (representing the
IFIS has also been reported in patients who had cytochrome P450-linked metabolising enzyme
discontinued tamsulosin for a longer period prior system).
to cataract or glaucoma surgery. Concomitant administration of tamsulosin with
The initiation of therapy with tamsulosin in strong inhibitors of CYP3A4 may lead to
patients for whom cataract or glaucoma surgery increased exposure to tamsulosin. Concomitant
is scheduled is not recommended. During pre- administration with ketoconazole (a known
operative assessment, cataract surgeons and strong CYP3A4 inhibitor) resulted in an increase
ophthalmic teams should consider whether in AUC and Cmax of tamsulosin by a factor of 2.8
patients scheduled for cataract or glaucoma and 2.2, respectively.
surgery are being or have been treated with Tamsulosin hydrochloride should not be given
tamsulosin in order to ensure that appropriate in combination with strong inhibitors of
measures will be in place to manage the IFIS CYP3A4 in patients with poor metaboliser
during surgery. CYP2D6 phenotype.
Tamsulosin should not be given in combination Tamsulosin should be used with caution in
with strong inhibitors of CYP3A4 in patients combination with strong and moderate inhibitors
with poor metaboliser CYP2D6 phenotype. of CYP3A4.
Tamsulosin should be used with caution in Concomitant administration of tamsulosin with
combination with strong and moderate inhibitors paroxetine, a strong inhibitor of CYP2D6,
of CYP3A4 such as erythromycin (see section resulted in a Cmax and AUC of tamsulosin that
4.5). had increased by a factor of 1.3 and 1.6,
4.5 Interaction with other medicinal products respectively, but these increases are not
and other forms of interaction considered clinically relevant.
Interaction studies have only been performed in Concurrent administration with another α1-
adults. adrenoreceptor antagonist can lead to
No interactions have been seen when tamsulosin hypotensive effects.
was given concomitantly with either atenolol, 4.6 Fertility, pregnancy and lactation
enalapril, or theophylline. Pregnancy and breast-feeding
Concomitant cimetidine brings about a rise in Tamsulosin hydrochloride is not indicated for
plasma levels of tamsulosin, whereas furosemide use in women.
a fall, but as levels remain within the normal
range posology need not be adjusted. Fertility
In vitro, neither diazepam nor propranolol, Ejaculation disorders have been observed in
trichlormethiazide, chlormadinone, short and long term clinical studies with
amitriptyline, diclofenac, glibenclamide, tamsulosin. Events of ejaculation disorder,
simvastatin and warfarin change the free fraction retrograde ejaculation and ejaculation failure
of tamsulosin in human plasma. Neither does have been reported in the post authorisation
tamsulosin change the free fractions of phase.
diazepam, propranolol, trichlormethiazide and 4.7 Effects on ability to drive and use
chlormadinone. machines
Diclofenac and warfarin may increase the No studies on the effects on the ability to drive
elimination rate of tamsulosin. and use machines have been performed.
However patients should be aware of the fact
Tamsulosin has not been found to interact with that dizziness can occur.
amitriptyline, salbutamol, glibenclamide or
4.8 Undesirable effects
 Tamsul osin Hydr ochloide 4 00 mcg Ca psule s TajPhar ma : Us es, Side E ffe cts, Intera ctions, Picture s, Warni ngs, Tamsulosin Hydrochl oride Dosage & Rx I nfo | Tams ulosin Hy drochloride Uses, Side E ffects - gastro-re sistant, Ta msulosin Hydr ochl oride : Indications, Side E ffe cts, War nings, Ta msul osin Hy drochl oride - Drug I nformation - TajP harma, Ta ms ulosin Hy drochloride dose Taj phar mace uticals Ta msul osin Hydr ochl oride intera ctions, Taj P harma ceuti cal Tams ulosi n Hydrochlori de contraindi cations, Ta ms ulosi n Hydrochloride price, Ta ms ulosin Hydrochloride TajPhar ma Antihyperten sive Tams ulosi n Hydrochl oride Ca psule s SMPC - TajPhar ma Stay connecte d to all update d on Ta ms ulosin Hydrochloride Taj Phar mace uticals Taj pharma ceutical s Mumbai. Patient I nformation Lea flets, SMPC.

Comm Uncom Rare Very Not subcutan Pruritus dema s- ema

on mon (≥1/10, rare know eous , Johnso multif
(≥1/10 (≥1/1,0 000 to (<1/10, n tissue Urticari n orm,
0 to 00 to <1/1,00 000) (cann disorder a syndro Derm
<1/10) <1/100) 0) ot be s me atitis
estima exfoli
ted ative
from Reprodu Ejacul Priapis
the ctive ation m
availa system disord
ble and ers
data) breast includi
Nervous Dizzin Headac Syncop disorder ng
system ess he e s Retrog
disorder (1.3%) rade
s ejacula
Eye Blurre tion,
disorder d Ejacul
s vision ation
*, failure
Impai General Astheni
red disorder a
vision s and
* administ
Cardiac Palpitat ration
disorder ions site
s conditio
Vascular Orthost ns
disorder atic *Observed in the post-marketing period
s hypoten During cataract and glaucoma surgery a small
sion pupil situation, known as Intraoperative Floppy
Respirat Rhinitis Epista Iris Syndrome (IFIS), has been associated with
ory, xis* therapy of tamsulosin during post-marketing
thoracic surveillance (see also section 4.4).
and Post-marketing experience: In addition to the
mediasti adverse events listed above, atrial fibrillation,
nal arrhythmia, tachycardia and dyspnoea have been
disorder reported in association with tamsulosin use.
s Because these spontaneously reported events are
Gastro- Constip Dry from the worldwide post marketing experience,
intestina ation, mouth the frequency of events and the role of
l Diarrho * tamsulosin in their causation cannot be reliably
disorder ea, determined.
s Nausea, Reporting of suspected adverse reactions
Vomiti
ng Reporting suspected adverse reactions after
authorisation of the medicinal product is
Skin and Rash, Angioe Steven Eryth
 Tamsul osin Hydr ochloide 4 00 mcg Ca psule s TajPhar ma : Us es, Side E ffe cts, Intera ctions, Picture s, Warni ngs, Tamsulosin Hydrochl oride Dosage & Rx I nfo | Tams ulosin Hy drochloride Uses, Side E ffects - gastro-re sistant, Ta msulosin Hydr ochl oride : Indications, Side E ffe cts, War nings, Ta msul osin Hy drochl oride - Drug I nformation - TajP harma, Ta ms ulosin Hy drochloride dose Taj phar mace uticals Ta msul osin Hydr ochl oride intera ctions, Taj P harma ceuti cal Tams ulosi n Hydrochlori de contraindi cations, Ta ms ulosi n Hydrochloride price, Ta ms ulosin Hydrochloride TajPhar ma Antihyperten sive Tams ulosi n Hydrochl oride Ca psule s SMPC - TajPhar ma Stay connecte d to all update d on Ta ms ulosin Hydrochloride Taj Phar mace uticals Taj pharma ceutical s Mumbai. Patient I nformation Lea flets, SMPC.

important. It allows continued monitoring of the Tamsulosin increases the maximum urinary flow
benefit/risk balance of the medicinal product. rate by relaxing prostatic and urethral smooth
4.9 Overdose muscle, thus relieving obstruction.
Symptoms The medicinal product also improves the
Overdosage with tamsulosin can potentially irritative and obstructive symptoms in which the
result in severe hypotensive effects. Severe contraction of smooth muscle in the lower
hypotensive effects have been observed at urinary tract plays an important role. Alpha-
different levels of overdosing. The largest dose blockers can reduce blood pressure by lowering
of tamsulosin that was administered to an peripheral resistance. No reduction in blood
individual patient accidentally was 12 mg. The pressure of any clinical significance was
patient developed a headache, but did not observed during studies with tamsulosin in
require hospital treatment. normotensive patients.
Management The medicinal product's effect on storage and
voiding symptoms are also maintained during
In case of acute hypotension occurring after long-term therapy, as a result of which the need
overdosage cardiovascular support should be for surgical treatment is significantly postponed.
given. Blood pressure can be restored and heart
rate brought back to normal by lying the patient Paediatric population
down. If this does not help then volume A double-blind, randomised, placebo-controlled,
expanders and when necessary, vasopressors dose ranging study was performed in children
could be employed. Renal function should be with neuropathic bladder. A total of 161 children
monitored and general supportive measures (with an age of 2 to 16 years) were randomised
applied. Dialysis is unlikely to be of help as and treated at 1 of 3 dose levels of tamsulosin
tamsulosin is very highly bound to plasma (low [0.001 to 0.002 mg/kg], medium [0.002 to
proteins. 0.004 mg/kg], and high [0.004 to 0.008 mg/kg]),
Measures such as emesis, can be taken to or placebo. The primary endpoint was number of
impede absorption. patients who decreased their detrusor leak point
pressure (LPP) to <40 cm H2O based upon two
If large quantities of the medicinal product are evaluations on the same day. Secondary
involved, gastric lavage may be performed and endpoints were: Actual and percent change from
activated charcoal and an osmotic laxative, such baseline in detrusor leak point pressure,
as sodium sulphate, may be given. improvement or stabilisation of hydronephrosis
5. Pharmacological properties and hydroureter and change in urine volumes
obtained by catheterisation and number of times
5.1 Pharmacodynamic properties wet at time of catheterisation as recorded in
Pharmacotherapeutic group: Drugs used in catheterisation diaries. No statistically
benign prostatic hypertrophy, alpha significant difference was found between the
adrenoreceptor antagonists. placebo group and any of the 3 tamsulosin dose
Mechanism of action groups for either the primary or any secondary
endpoints. No dose response was observed for
Tamsulosin binds selectively and competitively
any dose level.
to postsynaptic α1 adrenoreceptors, in particular
to subtypes α 1A and α 1D, which convey smooth 5.2 Pharmacokinetic properties
muscle contraction, thereby relaxing the Absorption
prostatic and urethral smooth muscle. Tamsulosin is rapidly absorbed from the
Pharmacodynamic effects intestines and its bioavailability is almost
complete. Absorption is slowed down if a meal
has been eaten before taking the medicinal
 Tamsul osin Hydr ochloide 4 00 mcg Ca psule s TajPhar ma : Us es, Side E ffe cts, Intera ctions, Picture s, Warni ngs, Tamsulosin Hydrochl oride Dosage & Rx I nfo | Tams ulosin Hy drochloride Uses, Side E ffects - gastro-re sistant, Ta msulosin Hydr ochl oride : Indications, Side E ffe cts, War nings, Ta msul osin Hy drochl oride - Drug I nformation - TajP harma, Ta ms ulosin Hy drochloride dose Taj phar mace uticals Ta msul osin Hydr ochl oride intera ctions, Taj P harma ceuti cal Tams ulosi n Hydrochlori de contraindi cations, Ta ms ulosi n Hydrochloride price, Ta ms ulosin Hydrochloride TajPhar ma Antihyperten sive Tams ulosi n Hydrochl oride Ca psule s SMPC - TajPhar ma Stay connecte d to all update d on Ta ms ulosin Hydrochloride Taj Phar mace uticals Taj pharma ceutical s Mumbai. Patient I nformation Lea flets, SMPC.

product. Uniformity of absorption can be 5.3 Preclinical safety data

assured by always taking tamsulosin after the Toxicity after a single dose and multiple dosing
same daily meal. has been investigated in mice, rats and dogs.
Tamsulosin shows linear kinetics. Reproductive toxicity has also been investigated
in rats, carcinogenicity in mice and rats, and
Peak plasma levels are achieved at genotoxicity in vivo and in vitro.
approximately six hours after a single dose of
tamsulosin taken after a full meal. The steady The common toxicity profile found with large
state is reached by day five of multiple dosing doses of tamsulosin is equivalent to the
when Cmax in patients is about two-thirds higher pharmacological effect associated with alpha
than that reached after a single dose. Although adrenergic antagonists.
this has been demonstrated only in the elderly, Changes in ECG readings were found with very
the same result would also be expected in large doses in dogs. This is not, however,
younger patients. assumed to be of any clinical significance.
There are huge inter-patient variations in plasma Tamsulosin has not been found to have any
levels of tamsulosin, both after single as well as significant genotoxic properties.
multiple dosing. Greater proliferative changes in the mammary
Distribution glands of female rats and mice have been
discovered on exposure to tamsulosin. These
In humans, tamsulosin is more than 99% bound findings, which are probably indirectly linked to
to plasma proteins and the volume of hyperprolactinaemia and only occur as a result
distribution is small (about 0.2 l/kg). of large doses having been taken, are considered
Biotransformation clinically insignificant.
Tamsulosin has a low first pass metabolic effect. 6. Pharmaceutical particulars
Most tamsulosin is found unaltered in plasma.
The substance is metabolised in the liver. 6.1 List of excipients
Content of capsule
In studies on rats, tamsulosin was found to cause
only a slight induction of microsomal liver Cellulose microcrystalline, Methacrylic acid-
enzymes. ethyl acrylate copolymer (1:1) dispersion 30 per
cent
In vitro results suggest that CYP3A4 and also
CYP2D6 are involved in metabolism, with Polysorbate, Sodium laurilsulfate, Triethyl
possible minor contributions to tamsulosin citrate and Talc.
hydrochloride metabolism by other CYP Capsule shell: Gelatin, Indigo carmine,
isozymes. Inhibition of CYP3A4 and CYP2D6 Titanium dioxide, Yellow iron oxide, Red iron
drug metabolizing enzymes may lead to oxide, Black iron oxide.
increased exposure to tamsulosin hydrochloride
6.2 Incompatibilities
(see sections 4.4 and 4.5).
Not applicable.
The metabolites are not as effective and toxic as
6.3 Shelf life
the active medicinal product itself.
3 years.
Elimination
6.4 Special precautions for storage
Tamsulosin and its metabolites are mainly Blister packs: Store in the original package.
excreted in the urine with about 9% of the dose
Capsule containers: Keep the container tightly
being present in unchanged form.
closed.
The elimination half-life of tamsulosin in
6.5 Nature and contents of container
patients is approximately 10 hours (when taken
after a meal) and 13 hours in the steady state.
 Tamsul osin Hydr ochloide 4 00 mcg Ca psule s TajPhar ma : Us es, Side E ffe cts, Intera ctions, Picture s, Warni ngs, Tamsulosin Hydrochl oride Dosage & Rx I nfo | Tams ulosin Hy drochloride Uses, Side E ffects - gastro-re sistant, Ta msulosin Hydr ochl oride : Indications, Side E ffe cts, War nings, Ta msul osin Hy drochl oride - Drug I nformation - TajP harma, Ta ms ulosin Hy drochloride dose Taj phar mace uticals Ta msul osin Hydr ochl oride intera ctions, Taj P harma ceuti cal Tams ulosi n Hydrochlori de contraindi cations, Ta ms ulosi n Hydrochloride price, Ta ms ulosin Hydrochloride TajPhar ma Antihyperten sive Tams ulosi n Hydrochl oride Ca psule s SMPC - TajPhar ma Stay connecte d to all update d on Ta ms ulosin Hydrochloride Taj Phar mace uticals Taj pharma ceutical s Mumbai. Patient I nformation Lea flets, SMPC.

PVC/PE/PVDC/Aluminium blister packs in

cardboard boxes containing 10, 14, 20, 28, 30,
50, 56, 60, 90, 100 and 500 modified-release
capsules.
HDPE capsule containers with PP child-resistant
closures containing 10, 14, 20, 28, 30, 50, 56,
60, 90, 100 or 500 modified-release capsules.
Not all pack sizes may be marketed.
6.6 Special precautions for disposal and other
handling
7. Manufactured In India By:
TAJ PHARMACEUTICALS LTD.
Mumbai, India
Unit No. 214.Old Bake House,
Maharashtra chambers of Commerce Lane,
Fort, Mumbai - 400001
at:Gujarat, INDIA.
Customer Service and Product Inquiries:
1-800-TRY-FIRST (1-800-222-434 & 1-800-
222-825)
Monday through Saturday 9:00 a.m. to 7:00 p.m.
EST
E-mail: tajgroup@tajpharma.com